Thursday, September 15, 2005 5:08:56 PM
Tench E-mail Re: GPS Personal Locator
I wrote: How much is the tracking subscription in year 2 (following the free initial year)? I know you can't usually talk about margins but I'll ask anyway...what kind of margin do we pull in on the hardware and on the software subscriptions?
His response (in part): There no hidden or overage fees. First year, $29.99 Unlimited GPS tracking. Year 2 and 3 etc, same price. What we have is different from the other similar products in the marketplace. For example, they will require a $7.50 month fee, $5.00 overage and many other fees. They do this because they don’t have a backend network to support the device. We do. They also will NEVER be able to fill orders in the 5 and 10 thousand plus range. They’re selling it via the internet but won’t be able to solidify large nationwide distributors or retailers. We are working with several organizations that are looking at scales of 5,10 and 15 thousand per month orders. The retail price of $489 is not what we realistically expect to get on a volume basis in the marketplace. That price would be equivalent to a single person walking into a Best buy and ordering one device. Our price to large retailers and organizations will be closer to $289 or even lower depending on volume. We get $20 of that $29.99 annual fee.
Looks good on my end...thoughts?
I wrote: How much is the tracking subscription in year 2 (following the free initial year)? I know you can't usually talk about margins but I'll ask anyway...what kind of margin do we pull in on the hardware and on the software subscriptions?
His response (in part): There no hidden or overage fees. First year, $29.99 Unlimited GPS tracking. Year 2 and 3 etc, same price. What we have is different from the other similar products in the marketplace. For example, they will require a $7.50 month fee, $5.00 overage and many other fees. They do this because they don’t have a backend network to support the device. We do. They also will NEVER be able to fill orders in the 5 and 10 thousand plus range. They’re selling it via the internet but won’t be able to solidify large nationwide distributors or retailers. We are working with several organizations that are looking at scales of 5,10 and 15 thousand per month orders. The retail price of $489 is not what we realistically expect to get on a volume basis in the marketplace. That price would be equivalent to a single person walking into a Best buy and ordering one device. Our price to large retailers and organizations will be closer to $289 or even lower depending on volume. We get $20 of that $29.99 annual fee.
Looks good on my end...thoughts?
Do your homework - hope is NOT a strategy!
Maddog
Recent FITY News
- Fifty 1 Labs, Inc. Accelerates Peptide Biotechnology Push into Musculoskeletal Health • ACCESS Newswire • 04/15/2026 12:30:00 PM
- Fifty 1 Labs, Inc. Eliminates 612 Million Shares from the Market • ACCESS Newswire • 04/14/2026 12:30:00 PM
- Fifty1 Labs, Inc. Clarifies Status Regarding Previously Announced Collaboration with LUNR Aerospace • GlobeNewswire Inc. • 01/05/2026 06:08:59 PM
- Fifty1 Labs, Inc. Clarifies Status Regarding Previously Announced Collaboration with LUNR Aerospace • InvestorsHub NewsWire • 01/05/2026 06:00:00 PM
- Fifty 1 Labs Inc. Appoints Dr. Joel Gagnier as Chief Science Officer • GlobeNewswire Inc. • 10/09/2025 02:23:35 PM
- Fifty 1 Labs Inc. Appoints Dr. Joel Gagnier as Chief Science Officer • InvestorsHub NewsWire • 10/09/2025 02:00:00 PM
- Fifty 1 Labs Inc. Signs Letter of Intent to Acquire BioSpark AI Technologies Inc. • GlobeNewswire Inc. • 09/30/2025 01:56:45 PM
- Fifty 1 Labs Inc. Signs Letter of Intent to Acquire BioSpark AI Technologies Inc. • InvestorsHub NewsWire • 09/30/2025 01:45:00 PM
- Fifty 1 Labs, Inc. Engages PCAOB Auditing Firm to Prepare for Uplist to OTCQB • GlobeNewswire Inc. • 09/23/2025 01:07:25 PM
- Fifty 1 Labs, Inc. Engages PCAOB Auditing Firm to Prepare for Uplist to OTCQB • InvestorsHub NewsWire • 09/23/2025 12:35:36 PM
- Fifty1 Labs, Inc. Leadership Publishes Landmark Framework to Unlock Global Oncology Data Through AI-Driven Real-World Evidence • InvestorsHub NewsWire • 09/04/2025 12:30:00 PM
- Fifty1 Labs Partners with LUNR Aerospace to Pioneer AI-Driven Drug Repurposing for Space Medicine, Strategic Collaboration Aims to Harness AI and Orbital Access to Revolutionize Astronaut Health Solutions in a $2 Billion Market by 2032 • InvestorsHub NewsWire • 08/26/2025 01:00:00 PM
- Fifty1 Labs, Inc. Subsidiary Fifty1 AI Labs Partners with ViRx@Stanford Under 'BE READI!' Initiative to Advance AI-Powered Antiviral Drug Repurposing • InvestorsHub NewsWire • 08/22/2025 02:30:00 PM
- Fifty1 Labs, Inc. and BioSpark AI Unlock 2,000+ Real-World Treatment Pathways to Accelerate Functional Medicine Innovation • InvestorsHub NewsWire • 08/12/2025 12:30:00 PM
- Fifty 1 Labs, Inc. Hosts Successful Virtual Shareholder Teleconference, Showcasing AI-Driven Functional Medicine Strategy and World-Class Leadership • InvestorsHub NewsWire • 07/29/2025 01:00:00 PM
- Fifty 1 Labs, Inc. to Host Virtual Shareholder Teleconference Featuring World-Class Leadership Team, including Dr. James Orbinski, who received the Nobel Peace Prize on Behalf of Médecins Sans Frontières • InvestorsHub NewsWire • 07/28/2025 12:30:00 PM
- Fifty 1 Labs, Inc. (FITY) Sparks AI Breakthrough in Drug Repurposing: Subsidiary Fifty1 AI Labs Announces Strategic Partnership with Intent to Acquire BioSpark AI Technologies • InvestorsHub NewsWire • 07/17/2025 12:30:00 PM
- Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • InvestorsHub NewsWire • 07/10/2025 12:30:49 PM
- Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • InvestorsHub NewsWire • 07/08/2025 12:30:00 PM
